Entasis Therapeutics Holdings Inc (ETTX) Stock Cash Flow
NASDAQ:ETTX - Nasdaq - US2936141033 - Common Stock
| TTM (2022-3-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -51.70M | -47.14M | -50.50M | -43.85M | -32.95M | |||
| Depreciation Amortization | 90.00K | 100.00K | 140.00K | 140.00K | 160.00K | |||
| Change In Working Capital | 1.13M | 40.00K | 2.02M | -2.77M | -4.49M | |||
| Taxes Paid | N/A | N/A | 0.00 | 680.00K | N/A | |||
| Other non cash items | 3.85M | 4.02M | 2.91M | 1.74M | 1.46M | |||
| OPERATING CASH FLOW | -46.62M | -42.97M | -45.43M | -44.74M | -35.82M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -70.00K | -70.00K | -20.00K | -110.00K | -370.00K | |||
| Other Investing Activity | N/A | 0.00 | 25.00M | 11.47M | -35.72M | |||
| INVESTING CASH FLOW | -70.00K | -70.00K | 24.98M | 11.36M | -36.09M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 20.30M | 22.10M | 57.66M | 210.00K | 100.00K | |||
| Other Financing Activity | N/A | N/A | N/A | -150.00K | 66.07M | |||
| FINANCING CASH FLOW | 35.30M | 22.10M | 57.66M | 60.00K | 66.17M | |||
| CHANGE IN CASH | -11.39M | -20.94M | 37.21M | -33.32M | -5.74M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -46.62M | -42.97M | -45.43M | -44.74M | -35.82M | |||
| Capital Expenditure | -70.00K | -70.00K | -20.00K | -110.00K | -370.00K | |||
| FREE CASH FLOW | -46.69M | -43.04M | -45.45M | -44.85M | -36.19M | |||
All data in USD